Reference
Health & biomedicine
The biomedicine sector: therapeutic platforms, diagnostics and monitoring, regenerative and personalised medicine.
The biomedical sector is built around three questions: what is happening in the body, how to change it, and how to verify the change. The clusters answer in order: diagnostics & medtech — measurement inside the body’s noise (affinity windows, Poisson counting, the Bayes arithmetic of screening); therapeutic platforms — delivery and selectivity as the standing trade; regenerative & personalised medicine — growing tissue and fitting therapy to one patient.
The sector’s recurring motif is the price of noise: every measurement in a living body competes with motion, degradation and immunity, and every treatment competes with the body’s drive to restore the status quo. The second motif is time: a diagnostic is worth not its accuracy but whether the answer arrives early enough to act on.
The sector’s entry point is diagnostics biosensors: the transduction and specificity vocabulary the other pages stand on.
- Therapeutics & platforms Delivery as the binding constraint from nucleic acids to vectors, process-defined biologics, and mechanisms whose precision is also their weakness.
- Diagnostics & medtech Why every method lives or dies by a quantity that bounds it — affinity window, error floor, prevalence — and how diagnosis moves to an answer in time.
- Regenerative & personalized What the body does to anything placed in or on it, potency versus yield in cell-derived products, and what a single outcome can and cannot establish.